Progesterone vaginal ring: Results of an acceptability study in Nigeria

Abstract

The progesterone vaginal ring (PVR) is used to extend the contraceptive effectiveness of lactational amenorrhea among breastfeeding women. The PVR was first registered in Chile and Peru in 1998 for use by postpartum women and has since been expanded to other Latin American countries. Previous studies have shown that contraceptive vaginal rings are safe, effective, and well accepted in varied cultural settings. However, the extent to which the ring is acceptable in the sub-Saharan African context is unknown. This study examined the acceptability of the PVR in Nigeria as part of a larger project that was also conducted in Kenya and Senegal. The specific objectives of the study were to assess the factors influencing the acceptability of the method among clients, their partners, providers, community members, and those who were counseled but did not choose the method, to inform future introduction efforts. Findings indicate that women and their partners, as well as family planning service providers, have positive attitudes toward the PVR, which is vital to its acceptance within the larger society

    Similar works